Document Detail


Psoriasis: the heart of the matter.
MedLine Citation:
PMID:  18280344     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Warren R. Heymann, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology.
Authors:
Warren R Heymann
Related Documents :
17707154 - Peutz-jeghers syndrome.
2303604 - Current trends in the practice of dermatologic surgery.
11645704 - Unesco conference on human rights and bioethics.
20432184 - American academy of allergy, asthma and immunology (aaaai)-2010 annual meeting. 26 febr...
11844334 - Gamete donation: ethical implications for donors.
20448004 - Is supervised community treatment ethically justifiable?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  58     ISSN:  1097-6787     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-02-18     Completed Date:  2008-03-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  477-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Artery Disease / etiology
Diabetes Complications / epidemiology
Heart Diseases / etiology*
Humans
Incidence
Psoriasis / complications*,  physiopathology
Risk
Risk Factors
Severity of Illness Index

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of blood-type tattoos during the Cold War.
Next Document:  CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.